about
Coordinate control of adipose 'browning' and energy expenditure by β-adrenergic and natriuretic peptide signallingObesity, Heart Failure, and Obesity ParadoxManifold implications of obesity in ischemic heart disease among Japanese patients according to covariance structure analysis: Low reactivity of B-type natriuretic peptide as an intervening risk factor.The obesity paradox in acute coronary syndrome: a meta-analysisThe relationship between leptin and ventilatory control in heart failureDual Angiotensin Receptor and Neprilysin Inhibition with Sacubitril/Valsartan in Chronic Systolic Heart Failure: Understanding the New PARADIGM.Impact of obesity on the expression profile of natriuretic peptide system in a rat experimental model.Highly specific detection of myostatin prodomain by an immunoradiometric sandwich assay in serum of healthy individuals and patients.Adiponectin is independently associated with NT-proBNP: The Multi-Ethnic Study of AtherosclerosisImpact of insulin resistance on silent and ongoing myocardial damage in normal subjects: the Takahata study.The influence of body composition on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with acute coronary syndrome: a cohort study.Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats.The effect of preoperative nutritional status on postoperative outcomes in children undergoing surgery for congenital heart defects in San Francisco (UCSF) and Guatemala City (UNICAR).Leptin deficiency promotes central sleep apnea in patients with heart failure.The obesity paradox in men with coronary heart disease and heart failure: the role of muscle mass and leptin.Sleep apnea is associated with subclinical myocardial injury in the community. The ARIC-SHHS study.Preoperative B-type natriuretic peptide levels are associated with outcome after total cavopulmonary connection (Fontan).Natriuretic peptides: molecular biology, pathophysiology and clinical implications for the cardiologist.Novel biomarkers for heart failure.The paradox of obesity cardiomyopathy and the potential for weight loss as a therapy.Complex relationship of obesity and obesity paradox in heart failure - higher risk of developing heart failure and better outcomes in established heart failure.Targeting cardiac natriuretic peptides in the therapy of diabetes and obesity.Short term variation in NTproBNP after lifestyle intervention in severe obesity.Conflicting relationship between age-dependent disorders, valvular heart disease and coronary artery disease by covariance structure analysis: Possible contribution of natriuretic peptide.Natriuretic Peptide System Activation in Acute Heart Failure Patients with DiabetesNTproBNP in insulin-resistance mediated conditions: overweight/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato StudyPlasma N-terminal pro-B-type natriuretic peptide concentration in healthy retired racing Greyhounds.The Application of Sodium-Glucose Cotransporter 2 Inhibitors to Chronic Kidney Disease Stage 4.The Initial Evaluation and Management of a Patient with Heart Failure.Expanding the role of cardiac biomarkers--natriuretic peptides and troponins--further in pre-Stage A.Impact of underlying heart disease per se on the utility of preoperative NT-proBNP in adult cardiac surgery.microRNA-132: a new biomarker of heart failure at last?Inverse Correlation of Venous Brain Natriuretic Peptide Levels with Body Mass Index Is due to Decreased Production.Serum proatrial natriuretic peptide does not increase with higher systolic blood pressure in obese men.Acute effects of insulin on circulating natriuretic peptide levels in humans.Metabolomic profiling implicates adiponectin as mediator of a favorable lipoprotein profile associated with NT-proBNP
P2860
Q27012896-F9CAEA0C-0453-48B7-8AB8-F9CF67558FB4Q33617505-6811F8F0-8E27-41A8-8D08-0169ADFE099DQ33648242-61C40E9E-3C01-44B2-B4DD-E6042BD6AA0FQ34445415-DB8ADC6E-358E-4030-A657-AC727DF5547AQ34455339-C51991DF-E20A-41DD-AB2C-B0A5C0630C19Q34485114-00AA49BB-2756-45D9-BCF6-4C17F63225FBQ34979675-0EA05A53-5DAE-462B-8E24-336276C29684Q35049028-082E4BF0-8FD1-4E33-A6E2-4EA5ACD380DDQ35889423-EAD0151C-9D12-49A9-84C0-15F7B37DA99DQ36326775-E928A1D4-08CF-40F7-9D74-793C2341EE8BQ36769441-DBD2ECB8-4509-4BEC-8B45-A99EC78CF2B7Q36903395-DEF90323-01D3-4788-8F3F-1BC2106840EBQ37209642-91F5EA1A-453A-4F73-896D-D55675848DA3Q37443421-6A08DDBE-1417-4F04-88E4-9861EEE776FCQ37539890-F7E45473-F999-4657-AAB2-9B2B3562893FQ37566536-FA858318-F02B-4601-92D9-1A4FEFF717E5Q37669708-5E82FAEC-A2BB-4888-AE3A-E2F3214ED94DQ38120091-505E5829-F18D-4B2C-9C72-961CA7CD6EA8Q38131790-51339EA0-2D2C-4EF7-9340-35DC7EE9DBF5Q38533878-11B73825-E4E3-44EF-B493-BC3B94E45B73Q38840828-EE793421-918B-4589-A292-279822F98462Q38992403-8D545A93-63F2-45D7-A046-034EB5FC60D1Q41007414-8A1B9205-4870-4446-B9BB-BDE37FDEE0C5Q41071466-737BC515-7A0A-4779-9CDC-E283B75C629BQ41448269-DFD51191-BD19-49B4-A5DD-CFD177CB47E7Q42363898-0269D690-12D8-4DD7-9D75-220E7EA1F867Q46727595-C7397AAE-5244-4A0E-8E3B-4C6D4E4CE1EAQ47110037-BE1859AB-E7FF-45DE-8400-BE1CFF572970Q47552207-DF6857B5-3A42-472C-BB1D-279DCC0DEDC1Q48516064-6A11BB7F-947C-423B-B51F-793B0FF8A5BEQ50053591-424E070B-5ADB-4C74-9701-DB44159459ADQ50100388-C0DC2C89-E5F3-46BA-8A8B-D0D0F21B1003Q50924829-A3FA2EDB-9B8C-4920-AFF7-7D5EDF1BE50FQ51280778-B21923F0-DE22-4B00-87EF-43CFC6AD644DQ54972286-234EABA9-2A3A-4AB7-91D5-7154628DF7D2Q57399030-9954335B-1D0A-452C-90B5-3DBDEC5CEB02
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The paradox of low BNP levels in obesity.
@en
The paradox of low BNP levels in obesity.
@nl
type
label
The paradox of low BNP levels in obesity.
@en
The paradox of low BNP levels in obesity.
@nl
prefLabel
The paradox of low BNP levels in obesity.
@en
The paradox of low BNP levels in obesity.
@nl
P2093
P2860
P1476
The paradox of low BNP levels in obesity.
@en
P2093
Aldo Clerico
Michele Emdin
Simona Vittorini
P2860
P2888
P356
10.1007/S10741-011-9249-Z
P577
2012-01-01T00:00:00Z